Abstract:Background Tuberculosis (TB) remains a major public health concern worldwide. Previous studies have demonstrated that IL-17 plays an important role in initial immune response and is involved in both immune-mediated protection and pathology following infection with Mycobacterium tuberculosis (MTB). However, the alterations and regulation of plasma IL-17 level during TB treatment remain unclear. Moreover, the cell type responsible for the production of IL-17 in TB patients requires further study. Methods A total of 20 acid-fast bacilli smear-positive (AFB-positive) pulmonary TB patients and 20 age- and gender-matched healthy volunteers were included in our study. Blood samples were collected in heparinized tubes at the time of diagnosis (AFB-positive group) and 3 weeks after the initiation of therapy, when the sputum smear conversion (AFB-negative group) occurred, followed by symptomatic improvement. IL-17 levels and IL-17-producing cells in PBMCs were detected. Lymphocyte populations in the peripheral blood between the AFB-positive and AFB-negative groups were compared by flow-cytometry. A549 cells, a cell line of alveolar epithelial cells, were applied to determine the extent of the pathological damage mediated by IL-17 following MTB infection. Recombinant human IL-10 was used to investigate the regulation of IL-17 expression after sputum smear conversion in AFB-positive pulmonary TB patients. Results Plasma IL-17 level were elevated in patients with sputum AFB-positive pulmonary TB, but substantially decreased after TB treatment and smear conversion. Our data indicate that NKT-like cells might be the main source of IL-17, in addition to conventional T cells in AFB-positive pulmonary TB patients. The secretion of IL-17 may be suppressed by regulatory T (Treg) cells and IL-10 during TB treatment. Moreover, the IL-17 levels were positively correlated to both the C-reactive protein and erythrocyte sedimentation rate. Therefore, IL-17 was capable of alveolar epithelial cell damage following MTB infection. Conclusion The increase in the frequency of Treg cells and IL-10 levels was associated with a decrease in IL-17 in patients receiving TB treatment. Thus, IL-10 and Tregs may function to inhibit immune-mediated pathology in TB patients.

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells Suppress Mycobacterium Tuberculosis Immunity in Patients with Active Disease

CD11b(+) Dendritic Cell-Mediated Anti-Mycobacterium Tuberculosis Th1 Activation is Counterregulated by CD103(+) Dendritic Cells Via IL-10

CTLA-4 Blockade Reverses the Foxp3+ T-regulatory-cell Suppression of Anti-Tuberculosis T-cell Effector Responses

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

Anti-tuberculosis Treatment Enhances the Production of IL-22 Through Reducing the Frequencies of Regulatory B Cell.

Elevated Expression of T-bet in Mycobacterial Antigen-Specific CD4(+) T Cells from Patients with Tuberculosis.

The immune characterization of interferon-β responses in tuberculosis patients

[The Effect of CD4+ CD25+ Regulatory T Cell Inactivation Combined with Levofloxacin on Murine Tuberculosis].

T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection

Mycobacterium Tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12.

Biological functions of Mycobacterium tuberculosis-specific CD4+T cells were impaired by tuberculosis pleural fluid

Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters

Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis

Mycobacterium Tuberculosis Culture Filtrate Protein 10-Specific Effector/Memory Cd4(+) And Cd8(+) T Cells In Tubercular Pleural Fluid, With Biased Usage Of T Cell Receptor V Beta Chains

A subset of CD1c + dendritic cells is increased in patients with tuberculosis and promotes Th17 cell polarization.

Myeloid-derived Suppressor Cells in Patients with Active Tuberculosis

STAT3 Regulation of Mtb-specific T Cell Function in Active Pulmonary Tuberculosis Patients.

Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment

Specific CD4 + T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis

Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control